These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
Preliminary Proxy Statement
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
x
|
Definitive Proxy Statement
|
|
o
|
Definitive Additional Materials
|
|
o
|
Soliciting Material Pursuant to 240.14a-11(c) or 240.14a-12
|
|
x
|
No fee required
|
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
1.
|
Title of each class of securities to which transaction applies:
|
|
2.
|
Aggregate number of securities to which transaction applies:
|
|
3.
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
4.
|
Proposed maximum aggregate value of transaction:
|
|
5.
|
Total fee paid:
|
|
|
o
|
Fees paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
1.
|
Amount Previously Paid:
|
|
2.
|
Form, Schedule or Registration Statement No.:
|
|
3.
|
Filing Party:
|
|
4.
|
Date Filed:
|
|
|
1.
|
To elect five persons to serve as our directors for a term of one year each. The nominees for election to our Board of Directors are named in the attached Proxy Statement, which is part of this Notice.
|
|
2.
|
To ratify the appointment of Moss Adams, LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2014.
|
|
3.
|
To hold an advisory vote to approve the compensation of our Named Executive Officers, as described in the Proxy Statement.
|
|
4.
|
To hold an advisory vote on the frequency of future advisory votes to approve the compensation of our Named Executive Officers.
|
|
5.
|
To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
|
|
By Order of the Board of Directors,
|
|
|
PRO-DEX, INC.
|
|
|
/s/ Harold A. Hurwitz
|
|
|
Corporate Secretary
|
| 1 |
| 2 |
|
Name of Beneficial Owner
(1)
|
Number of Shares of Common
Stock Beneficially Owned
(2)
|
Percent of Common Stock
Beneficially Owned
(3)
|
|||||
|
Nicholas J. Swenson; AO Partners I, L.P.; and AO Partners, LLC
(4)
3033 Excelsior Blvd., Suite 560
Minneapolis, MN 55416
|
|
720,753
|
|
|
21.6
|
%
|
|
|
Raymond E. Cabillot; Farnam Street Partners, L.P.; Farnam Street Capital, Inc.;
and, Peter O. Haeg (5)
3033 Excelsior Blvd., Suite 320
Minneapolis, Minnesota 55416
|
|
354,371
|
|
|
10.6
|
%
|
|
|
First Wilshire Securities Management, Inc.
(6)
1224 East Green Street
Pasadena, California 91106
|
|
214,456
|
|
|
6.4
|
%
|
|
|
Mark P. Murphy
21295 Clear Haven Drive
Yorba Linda, California 92886
|
|
197,045
|
|
|
5.9
|
%
|
|
|
Richard L. Van Kirk, Jr.
(7)
|
56,390
|
1.7
|
%
|
||||
|
Harold A. Hurwitz
(7)
|
|
44,722
|
|
|
1.3
|
%
|
|
|
David C. Hovda
(7)
|
|
15,000
|
|
|
*
|
||
|
Michael J. Berthelot
|
|
11,667
|
|
|
*
|
||
|
William J. Farrell III
|
1,000
|
—
|
* | ||||
|
All Named Executive Officers, directors and director nominees as a group (7 persons)
|
|
1,203,903
|
|
|
34.9
|
%
|
|
|
*
|
Less than 1%.
|
|
1.
|
Unless otherwise indicated, the address is c/o Pro-Dex, Inc., 2361 McGaw Avenue, Irvine, California 92614.
|
|
2.
|
Unless otherwise indicated, to our knowledge, the persons named in the table have sole voting and sole investment power with respect to all shares beneficially owned, subject to community property and similar laws, where applicable.
|
|
3.
|
Applicable percentage ownership is based on 3,343,988 shares of Common Stock outstanding as of October 10, 2013. Any securities not outstanding but subject to warrants or options exercisable as of October 10, 2013, or exercisable within 60 days after such date, are deemed to be outstanding for the purpose of computing the percentage of outstanding Common Stock beneficially owned by the person holding such warrants or options, but are not deemed to be outstanding for the purpose of computing the percentage of Common Stock beneficially owned by any other person.
|
|
AO Partners, LLC is the General Partner of AO Partners I, L.P. Mr. Swenson is the Managing Member of AO Partners, LLC, and, in such capacity, has the power to direct the affairs of AO Partners, LLC, including the voting and disposition of shares of our Common Stock held by AO Partners I, L.P. As such, AO Partners I, L.P., AO Partners, LLC and Mr. Swenson may be deemed to share voting and dispositive power with regard to the 720,753 shares of our Common Stock held by AO Partners I, L.P.
|
|
|
5.
|
Farnam Street Partners, L.P., Farnam Street Capital, Inc., Raymond E. Cabillot, and Peter O. Haeg claim shared voting power and shared dispositive power of 354,371 shares of our Common Stock held by Farnam Street Partners, L.P.
|
|
First Wilshire Securities Management, Inc. claims sole voting power of 666 shares and sole dispositive power of 214,456 shares.
|
|
|
7.
|
Includes shares of Common Stock issuable upon the exercise of options that were exercisable as of October 10, 2013, or exercisable within 60 days after October 10, 2013, as follows: Mr. Hovda, 15,000 shares, Mr. Hurwitz, 39,722 shares, Mr. Van Kirk, 51,390 shares; and all directors, director nominees and Named Executive Officers as a group, 106,112 shares.
|
| 3 |
|
Name
|
Age
|
Position With Company
|
Audit
|
Compensation
|
Nominating and
Governance |
||||||
|
Raymond E. Cabillot
|
50
|
Director
|
X
|
X
|
C
|
||||||
|
William J. Farrell III
|
40
|
Director
|
X
|
X
|
|||||||
|
David C. Hovda
|
51
|
Director
|
C
|
X
|
|||||||
|
Harold A. Hurwitz
|
61
|
Director, Chief Executive Officer, President, Chief Financial Officer
|
|||||||||
|
Nicholas J. Swenson
|
45
|
Director, Chairman of the Board
|
X
|
C
|
X
|
||||||
|
(X)
|
Member of the Committee
|
|
(C)
|
Chairman of the Committee
|
|
●
|
Four years of prior public company board experience, including three years as Chairman and one year as Co-Chairman; and
|
|
●
|
Independent of our management.
|
| 4 |
|
●
|
Current senior-level management, operating and board experience;
|
|
●
|
More than 12 years of experience in engineering and management roles in the medical device industry, our primary target market; and
|
|
●
|
Independent of our management.
|
|
●
|
Current senior-level management, operating and board experience based on 20 years of participation in the medical device industry, our primary target market, eight years of which are specifically with medical devices to treat disorders of the spine, a sector within the medical device industry that we believe represents potential for future revenue growth;
|
|
●
|
Core management and leadership skills gained through experience overseeing and managing operations at the manager and chief executive officer levels, including experience in medical device intellectual property, product development, clinical testing and marketing;
|
|
●
|
Experience in financial analysis, including operational restructuring, acquisition opportunities and market entry feasibility; and
|
|
●
|
Independent of our management.
|
| 5 |
|
●
|
37 years of experience in accounting, reporting and financial management based on 22 years as an employee and partner with Coopers & Lybrand L.L.P. and 15 years as a chief financial officer and financial consultant;
|
|
●
|
10 years as a chief financial officer of publicly held companies, including three years as our Chief Financial Officer; and
|
|
●
|
29 years of senior-level management, operating and consulting experience in the medical device industry, our primary target market.
|
|
●
|
17 years of experience as a financial analyst and investment manager;
|
|
●
|
Public company board experience; and
|
|
●
|
Independent of our management
|
| 6 |
| 7 |
| 8 |
|
●
|
We pay competitively. We are committed to providing a pay program that helps attract and retain highly qualified people in the industry. To ensure that pay is competitive, we compare our pay practices with those of other leading companies of similar size and location(s) and set our pay parameters based on this review.
|
|
●
|
We pay for sustained performance. Executive officers are rewarded based upon corporate performance and individual performance. Corporate performance is evaluated by the Compensation Committee by reviewing the extent to which strategic and business plan goals are met, including such factors as revenues, operating profit and cash flow.
|
|
●
|
We strive for fairness in the administration of pay and to achieve a balance of the compensation paid to a particular individual as compared to the compensation paid to both our executives and executives at comparable companies.
|
|
●
|
We believe that employees should understand the performance evaluation and pay administration process.
|
|
●
|
Incentives are capped at a maximum amount regardless of the degree to which objectives may be exceeded.
|
|
●
|
Payments are based upon audited year end results.
|
|
●
|
Multiple objectives are used as performance targets.
|
|
●
|
Computations are reviewed at regular intervals during the year and are subject to multiple levels of review at the management, committee, and full Board level.
|
|
●
|
All incentives are based upon pre-established objective criteria as approved by our Board.
|
| 9 |
|
Name and
Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
(1)
|
Option
Awards
($)
(2)
|
Incentive
Plan
Compensation
($)
|
All Other
Compensation
($)
(3)
|
Total
($)
|
|||||||||||||||||||||||
|
Harold A. Hurwitz
(4)
|
2013
|
|
$
|
192,311
|
|
$
|
—
|
|
$
|
8,650
|
|
$
|
6,227
|
|
$
|
—
|
|
$
|
12,048
|
|
$
|
219,236
|
|
||||||||
|
Director, CEO, President, CFO, Treasurer and Secretary
|
2012
|
|
$
|
185,075
|
|
$
|
4,625
|
|
$
|
—
|
|
$
|
21,265
|
|
$
|
—
|
|
$
|
6,494
|
|
$
|
217,459
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Richard L. Van Kirk
(5)
|
2013
|
|
$
|
157,011
|
|
$
|
—
|
|
$
|
8,650
|
$
|
6,227
|
|
$
|
—
|
|
$
|
16,511
|
|
$
|
188,399
|
|
|||||||||
|
COO
|
2012
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
||||||||
|
Michael J. Berthelot
(6)
|
2013
|
|
$
|
195,852
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
173,174
|
|
$
|
369,026
|
|
||||||||
|
Director, CEO
|
2012
|
|
$
|
52,888
|
|
$
|
—
|
|
$
|
—
|
|
$
|
190,431
|
|
$
|
—
|
|
$
|
—
|
|
$
|
243,319
|
|
||||||||
|
and President
|
|||||||||||||||||||||||||||||||
| (1) |
This column represents the dollar amount recognized for financial statement reporting purposes with respect to the years ended June 30, 2013 and 2012, for the fair value of stock awards granted to each of our Named Executive Officers calculated in accordance with FASB ASC Topic 718. Pursuant to applicable SEC regulations, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to the restricted stock awards, refer to Notes To Consolidated Financial Statements set forth in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013. These amounts reflect only our accounting expense for these stock awards and do not correspond to the actual value that will be recognized by our Named Executive Officers.
|
|
(2)
|
This column represents the dollar amount recognized for financial statement reporting purposes with respect to the years ended June 30, 2013 and 2012, for the fair value of stock options granted to each of our Named Executive Officers calculated in accordance with FASB ASC Topic 718. Pursuant to applicable SEC regulations, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to these option grants, refer to Notes To Consolidated Financial Statements set forth in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013. These amounts reflect only the expense to be recognized for financial statement purposes and do not correspond to the actual value that will be recognized by our Named Executive Officers. See the table of Outstanding Equity Awards at June 30, 2013, below, for more information on options held by the Named Executive Officers. Stock options awarded have a term of ten years; vest in equal monthly or annual installments as per the applicable option agreement over a period of up to four years, and have an exercise price equal to either (a) the average of the high and low prices of our Common Stock on the Nasdaq Capital Market on the date of grant for options granted under our First Amended and Restated 2004 Stock Option Plan, or (b) the closing price of our Common Stock on the Nasdaq Capital Market on the last business day prior to the date of grant in which a closing price is available for options granted under our Second Amended and Restated 2004 Stock Option Plan.
|
|
(3)
|
All Other Compensation consists of:
|
|
Name
|
|
|
Year
|
|
Life and
health insurance premium payments |
|
Matching
contributions to the Company’s 401(k) plan |
|
Separation
agreement payments |
|
Total ($)
|
||||||||||
|
Harold A. Hurwitz
|
|
2013
|
|
|
$
|
9,914
|
|
|
$
|
2,134
|
|
|
$
|
—
|
|
|
$
|
12,048
|
|
||
|
|
2012
|
|
|
$
|
5,854
|
|
|
$
|
640
|
|
|
$
|
—
|
|
|
$
|
6,494
|
|
|||
|
Richard L. Van Kirk
|
|
2013
|
|
|
$
|
14,964
|
|
|
$
|
1,547
|
|
|
$
|
—
|
|
|
$
|
16,511
|
|
||
|
|
2012
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|||
|
Michael J. Berthelot
|
|
2013
|
|
|
$
|
2,640
|
|
|
$
|
3,140
|
|
|
$
|
167,394
|
|
|
$
|
173,174
|
|
||
|
|
2012
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|||
|
(4)
|
Mr. Hurwitz was appointed our Chief Executive Officer and President on February 25, 2013, in addition to continuing his position as CFO, Treasurer and Secretary.
|
|
(5)
|
Mr. Van Kirk was appointed our Chief Operating Officer on April 23, 2013. Mr. Van Kirk did not qualify as a Named Executive Officer prior to such appointment.
|
| 10 |
|
(6)
|
Mr. Berthelot’s employment with us commenced April 20, 2012 and concluded on February 25, 2013. Of the Option Awards granted to Mr. Berthelot in 2012, 100% expired unexercised upon the conclusion of Mr. Berthelot’s employment with us.
|
|
●
|
A base salary at an annualized rate of $225,000.
|
|
●
|
Participation in our Annual Incentive Plan and Long Term Incentive Plan.
|
|
●
|
Mr. Hurwitz is permitted to participate in any program of stock options or other equity grants that we may from time to time provide key employees. Such grants are made under the terms and provisions of the Second Amended and Restated 2004 Stock Option Plan or a successor stock incentive plan as may be approved by our Board.
|
|
●
|
Health, dental, disability and life insurance, qualified retirement plans, and optional employee benefits on the same terms as other employees, except Mr. Hurwitz will not participate in the Company-wide employee bonus plan.
|
|
●
|
A base salary at an annualized rate of $180,000.
|
|
●
|
Participation in our Annual Incentive Plan and Long Term Incentive Plan.
|
|
●
|
Mr. Van Kirk is permitted to participate in any program of stock options or other equity grants that we may from time to time provide key employees. Such grants are made under the terms and provisions of the Second Amended and Restated 2004 Stock Option Plan or a successor stock incentive plan as may be approved by our Board.
|
|
●
|
Health, dental, disability and life insurance, qualified retirement plans, and optional employee benefits on the same terms as other employees, except Mr. Van Kirk will not participate in the Company-wide employee bonus plan.
|
| 11 |
| 12 |
|
Option Awards
|
Stock Awards
|
||||||||||||
|
Name
|
|
Number of
Securities Underlying Unexercised Options Exercisable |
Number of
Securities Underlying Unexercised Options Unexercisable |
Option
Exercise Price |
Option Expiration Date
|
Number of
Shares or Units of Stock That Have Not Vested |
Market
Value of Shares or Units of Stock That Have Not Vested |
||||||
|
Harold A. Hurwitz
|
17,778
|
2,222
|
$1.97
|
October 7, 2020
|
|||||||||
|
14,582
|
10,418
|
$1.80
|
September 12, 2021
|
||||||||||
|
—
|
5,000
|
$1.73
|
September 11, 2022
|
||||||||||
|
5,000
|
$ 9,500
|
||||||||||||
|
Richard L. Van Kirk
|
8,334
|
—
|
$7.65
|
January 6, 2016
|
|||||||||
|
3,334
|
—
|
$4.38
|
May 18, 2017
|
||||||||||
|
17,778
|
2,222
|
$1.97
|
October 7, 2020
|
||||||||||
|
14,582
|
10,418
|
$1.80
|
September 12, 2021
|
||||||||||
|
—
|
5,000
|
$1.73
|
September 11, 2022
|
||||||||||
|
5,000
|
$ 9,500
|
||||||||||||
|
Michael J. Berthelot
|
—
|
—
|
—
|
—
|
—
|
—
|
|||||||
| 13 |
|
Annual retainer for each director
|
|
$
|
24,000
|
|
|
Additional annual retainer for service as:
|
|
|||
|
Lead Director/Chairman
|
|
$
|
7,000
|
|
|
Committee Chair
|
|
$
|
5,000
|
|
|
●
|
Fees of $200 for participation in Board or Committee meetings, to a maximum of $2,000 per fiscal year; and
|
|
●
|
An annual retainer of $23,000 for the Audit Committee Chair (which may be modified in compensating any future Audit Committee Chair).
|
| 14 |
|
Name
|
|
|
Fees Earned
or Paid in Cash ($) (1) |
|
Option Awards
($) (2) |
|
Total ($)
|
||||||
|
George J. Isaac
(3)
|
|
$
|
25,510
|
|
|
—
|
|
|
$
|
25,510
|
|
||
|
David Holder
(4)
|
|
$
|
26,010
|
|
|
—
|
|
|
$
|
26,010
|
|
||
|
William J. Healey
(5)
|
|
$
|
36,287
|
|
|
$
|
13,917
|
|
|
$
|
50,204
|
|
|
|
Michael J. Berthelot
(6)
|
|
$
|
4,014
|
|
|
—
|
|
|
$
|
4,014
|
|
||
|
David C. Hovda
(7)
|
|
$
|
7,250
|
|
|
$
|
22,749
|
|
|
$
|
29,999
|
|
|
|
William J. Farrell III
(8)
|
|
$
|
1,000
|
|
|
—
|
|
|
$
|
1,000
|
|
||
|
Nicholas J. Swenson
(8)
|
|
$
|
1,200
|
|
|
—
|
|
|
$
|
1,200
|
|
||
|
Raymond E. Cabillot
(8)
|
|
$
|
1,200
|
|
|
—
|
|
|
$
|
1,200
|
|
||
|
(1)
|
Cash compensation is based on the annual retainers and per meeting fees under the 2010 Directors’ Compensation Plan and the 2013 Directors’ Compensation Plan, as applicable.
|
|
(2)
|
This column represents the dollar amount recognized for financial statement reporting purposes with respect to the year ended June 30, 2013 for the fair value of stock options granted to each of our directors calculated in accordance with FASB ASC Topic 718. Pursuant to applicable SEC regulations, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to these option grants, refer to Notes To Consolidated Financial Statements set forth in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013. These amounts reflect only the expense to be recognized for financial statement purposes and do not correspond to the actual value that will be recognized by our directors.
|
|
(3)
|
Mr. Isaac’s position as a Board member terminated on January 17, 2013.
|
|
(4)
|
Mr. Holder’s position as a Board member terminated on January 17, 2013.
|
|
(5)
|
Upon Mr. Healey’s re-election as a director in January 2013, he was granted an option to purchase 10,000 shares of our Common Stock at a per share price of $2.14. Mr. Healey’s position as a Board member terminated on June 7, 2013.
|
|
(6)
|
Mr. Berthelot’s position as a Board member terminated on January 17, 2013.
|
|
(7)
|
Upon Mr. Hovda’s election as a director in January 2013, he was granted an option to purchase 15,000 shares of our Common Stock at a per share price of $2.14.
|
|
(8)
|
Messrs. Farrell, Swenson and Cabillot were elected as directors in January 2013. As described elsewhere in this proxy statement, Messrs. Farrell, Swenson and Cabillot each waived the stock options and certain fees they were otherwise entitled to under the 2010 Directors' Compensation Plan.
|
|
Plan Category
|
Number of Securities
to be Issued Upon
Exercise of
Outstanding Options,
Warrants and Rights
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants, and Rights
|
Number of Securities
Available for Issuance
Under Equity
Compensation Plans
(excluding services
reflected in column (a))
|
|||||||||||
|
(a)
|
(b)
|
(c)
|
||||||||||||
|
Plans Approved by Stockholders:
|
||||||||||||||
|
Second Amended and Restated 2004 Stock Option Plan
|
276,670
|
|
$
|
2.33
|
|
439,133
|
|
|||||||
|
Amended and Restated 2004 Directors’ Stock Option Plan
|
48,334
|
|
$
|
2.49
|
|
140,000
|
|
|||||||
| 15 |
|
David C. Hovda
|
Raymond E. Cabillot
|
Nicholas J. Swenson
|
| 16 |
| 17 |
|
|
Years Ended June 30,
|
|||||||
|
|
2013
|
|
2012
|
|||||
|
Audit Fees
(
1)
|
|
$
|
172,125
|
|
|
$
|
153,500
|
|
|
Audit-Related Fees
(
2)
|
|
$
|
4,280
|
|
|
12,030
|
|
|
|
Tax Fees
(
3)
|
|
$
|
36,410
|
|
|
$
|
22,140
|
|
|
All Other Fees
(
4)
|
|
—
|
|
|
—
|
|
||
|
|
|
|||||||
|
Total
|
|
$
|
215,815
|
|
|
$
|
187,670
|
|
|
(1)
|
Audit Fees
consist of fees billed for professional services rendered for the audit of our consolidated annual financial statements and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided in connection with statutory and regulatory filings or engagements.
|
|
(2)
|
Audit-Related Fees
consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under “Audit Fees.”
|
|
(3)
|
Tax Fees
consist of fees billed for professional services rendered for tax compliance, tax advice and tax planning. These services include assistance regarding federal state and local tax compliance, planning and advice.
|
|
(4)
|
All Other Fees
consist of fees for products and services other than the services reported above.
|
| 18 |
| 19 |
|
By Order of the Board of Directors,
|
|
|
PRO-DEX, INC.
|
|
|
/s/ Harold A. Hurwitz
|
|
|
Corporate Secretary
|
|
|
Irvine, California
|
| 20 |
|
PRO-DEX, INC.
2361 MCGAW AVENUE
IRVINE, CA 92614
|
|
VOTE BY INTERNET - www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.
Electronic Delivery of Future PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
|
|
For
All
|
|
Withhold
All
|
|
For All
Except
|
|
To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.
|
|
|
|
|
||||||||
|
The Board of Directors recommends you vote FOR each of the following director nominees:
|
|
|
|
|
|
|
|
|
||||||||||||
|
1.
|
|
Election of Directors Nominees
|
|
¨
|
|
¨
|
|
¨
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
01
|
|
Raymond E. Cabillot 02 William J. Farrell III 03 David C. Hovda 04 Harold A. Hurwitz 05 Nicholas J. Swenson
|
||||||||||||||||||
|
|
For
|
|
Against
|
|
Abstain
|
|
||||||||||||||
|
2
|
|
To ratify the appointment of Moss Adams, LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2014.
|
|
¨
|
|
¨
|
|
¨
|
|
|||||||||||
|
3
|
|
Advisory vote to approve the compensation of our Named Executive Officers.
|
|
¨
|
|
¨
|
|
¨
|
|
|||||||||||
|
The Board of Directors recommends you vote for 1 Year with respect to proposal 4.
|
1 Year | 2 Years |
3
Years
|
Abstain
|
||||||||||||||||
|
4
|
Advisory vote on the frequency of future advisory votes to approve the compensation of our Named Executive Officers.
|
¨
|
¨
|
¨
|
¨
|
|||||||||||||||
|
NOTE:
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|||||||
| Signature [PLEASE SIGN WITHIN BOX] | Date |
|
Signature (Joint Owners)
|
Date
|
|
|||||||
|
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Combined Document, Shareholder Letter is/are available at
www.proxyvote.com
.
|
|
PRO-DEX, INC.
Annual Meeting of Shareholders
December 5, 2013 8:00 AM
This proxy is solicited by the Board of Directors
|
||||
|
The undersigned hereby appoints Harold A. Hurwitz as attorney and proxy, with full power of substitution, to represent and vote, as designated below, all shares of Common Stock of Pro-Dex, Inc. held of record by the undersigned on October 10, 2013, at the Annual Meeting of Shareholders to be held at Pro-Dex, Inc., 2361 McGaw Avenue, on December 5, 2013, at 8:00 a.m., local time, and at any and all adjournments or postponements thereof.
This proxy, when properly executed, will be voted in the manner directed herein by the undersigned shareholder. If no direction is made, this proxy will be voted “FOR” each of the director nominees in proposal 1, “FOR” proposals 2 and 3, and “1 YEAR” with respect to proposal 4.
|
||||
|
Continued and to be signed on reverse side
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|